文献速递泌尿生殖MRUS

多参数前列腺MRI检出的前列腺影像报告和数据系统3类(不确定性)病变与临床显著性前列腺癌风险的相关性

Risk of Clinically Significant Prostate Cancer Associated With Prostate Imaging Reporting and Data System Category 3 (Equivocal) Lesions Identified on Multiparametric Prostate MRI.
PubMed 文献 · AJR Am J Roentgenol · 2017-11-07

研究纳入977例连续接受多参数前列腺MRI的男性,其中342例接受MRI-超声融合靶向活检,回顾性分析111个PI-RADS 3类病变;临床显著性癌(Gleason≥7)占17.1%,年龄较大、前列腺体积较小和直肠指检异常是显著预测因素,合并≥2个危险因素时临床显著性癌检出率为67%。

要点

  • PI-RADS 3类病变中临床显著性癌占17.1%,良性占73.0%。
  • 年龄较大、前列腺体积较小、直肠指检异常是临床显著性癌的独立预测因素。
  • 合并≥2个危险因素时临床显著性癌检出率67%,敏感度53%、特异度95%。

核心结论

  • 将临床参数纳入风险分层算法可能提高PI-RADS 3类病变中临床显著性疾病的检出能力,并可能有助于决定是否进行活检。

研究设计与样本

  • 回顾性研究,2015年1月至2016年7月共977例连续男性接受多参数前列腺MRI,其中342例接受MRI-超声融合靶向活检,回顾性分析474个病变,111个评为PI-RADS 3类,使用3-T MRI扫描仪,由经过PI-RADS第2版培训的体部亚专科放射科医生前瞻性解读。

诊断标准与关键数值

  • 临床显著性癌定义为靶向活检Gleason评分至少7;111个PI-RADS 3类病变中良性81个(73.0%)、临床不显著(Gleason评分6)11个(9.9%)、临床显著19个(17.1%);多变量分析中年龄较大(OR 1.13,p=0.002)、前列腺体积较小(OR 0.94,p=0.008)、直肠指检异常(OR 3.92,p=0.03)为显著预测因素;PI-RADS 3类病变合并0、1、2、3个危险因素时临床显著性癌风险分别为4%、16%、62%、100%;合并≥2个危险因素(如年龄≥70岁、腺体大小≤36 mL或直肠指检异常)时检出率67%,敏感度53%、特异度95%、阳性预测值67%、阴性预测值91%。

临床应用与阅片要点

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: The objective of this study is to determine the frequency of clinically significant cancer (CSC) in Prostate Imaging Reporting and Data System (PI-RADS) category 3 (equivocal) lesions prospectively identified on multiparametric prostate MRI and to identify risk factors (RFs) for CSC that may aid in decision making.

MATERIALS AND METHODS: Between January 2015 and July 2016, a total of 977 consecutively seen men underwent multiparametric prostate MRI, and 342 underwent MRI-ultrasound (US) fusion targeted biopsy. A total of 474 lesions were retrospectively reviewed, and 111 were scored as PI-RADS category 3 and were visualized using a 3-T MRI scanner. Multiparametric prostate MR images were prospectively interpreted by body subspecialty radiologists trained to use PI-RADS version 2. CSC was defined as a Gleason score of at least 7 on targeted biopsy. A multivariate logistic regression model was constructed to identify the RFs associated with CSC.

RESULTS: Of the 111 PI-RADS category 3 lesions, 81 (73.0%) were benign, 11 (9.9%) were clinically insignificant (Gleason score, 6), and 19 (17.1%) were clinically significant. On multivariate analysis, three RFs were identified as significant predictors of CSC: older patient age (odds ratio [OR], 1.13; p = 0.002), smaller prostate volume (OR, 0.94; p = 0.008), and abnormal digital rectal examination (DRE) findings (OR, 3.92; p = 0.03). For PI-RADS category 3 lesions associated with zero, one, two, or three RFs, the risk of CSC was 4%, 16%, 62%, and 100%, respectively. PI-RADS category 3 lesions for which two or more RFs were noted (e.g., age ≥ 70 years, gland size ≤ 36 mL, or abnormal DRE findings) had a CSC detection rate of 67% with a sensitivity of 53%, a specificity of 95%, a positive predictive value of 67%, and a negative predictive value of 91%.

CONCLUSION: Incorporating clinical parameters into risk stratification algorithms may improve the ability to detect clinically significant disease among PI-RADS category 3 lesions and may aid in the decision to perform biopsy.

来源:AJR Am J Roentgenol,查看原文。版权归原作者所有。

引用

  1. Sheridan AD, Nath SK, Syed JS, et al. Risk of Clinically Significant Prostate Cancer Associated With Prostate Imaging Reporting and Data System Category 3 (Equivocal) Lesions Identified on Multiparametric Prostate MRI. AJR Am J Roentgenol. 2017. PMID: 29112469. doi:10.2214/AJR.17.18516

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。